We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-5.45%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$54.1M
AUM Growth
-$14M
Cap. Flow
-$9.89M
Cap. Flow %
-18.29%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$9.89M

Sector Composition

Rank Sector Weight
1 Healthcare 88.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$39.4M 72.86%
1,753,000
-445,800
-20% -$9.89M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$8.42M 15.57%
3,791,300
– –
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$3.33M 6.15%
59,400
– –
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$2.93M 5.42%
60,700
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q2 2024 Portfolio in Review

As of Q2 2024, Meditor Group held 4 positions worth $54.1M, down 21% from $68M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $9.89M in Q2 2024, reducing 1 holding. Its largest reduction was Exelixis, cutting an estimated $9.89M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 92% a quarter earlier.

  • Meditor Group's biggest Q2 2024 reduction was Exelixis, cutting an estimated $9.89M.
  • Meditor Group's ten largest holdings make up 100% of its $54.1M portfolio in Q2 2024.
  • Meditor Group opened 0 new positions and closed 0 in Q2 2024.
  • Meditor Group's portfolio value fell 21% quarter-over-quarter to $54.1M.

Based on Meditor Group's 13F filing for Q2 2024, filed 22 Jul 2024.